openPR Logo
Press release

Transmyocardial Laser Revascularization Market to Develop Rapidly by 2025

03-09-2018 11:34 AM CET | Health & Medicine

Press release from: Transparency Market Research

Transmyocardial Laser Revascularization Market to Develop

Transmyocardial laser revascularization has emerged as a better treatment alternative for ischemic heart disease patients who are unable to undergo surgeries such as coronary artery bypass graft surgery or stenting by balloon angioplasty. Introduced in 1990, transmyocardial laser revascularization (TMLR) procedure bores small holes from the ventricle into the myocardium and provides significant relief to angina patients by allowing the direct flow of blood to heart muscles, thereby surpassing the need to transport supporting device such as coronary guidewires through blocked arteries. The growing patient population suffering from weakened blood veins owing to type 2 diabetes, obesity, and other conditions resulting in metabolic disorders has led to increased need for thorough investigation of transmyocardial laser revascularization as an effective substitute for difficult-to-treat patients.

Reduced probability of re-admission, along with improvement in quality of life of the patient are likely to drive the growth of the global Transmyocardial Laser Revascularization Market during the forecast period. Currently, nearly 40% of the overall transmyocardial laser revascularization procedures are performed in the U.S. alone, which reflects the significant growth opportunity for improvement in the adoption rate of the transmyocardial laser revascularization technique in other high growth potential developing countries. However, requirement of skilled personnel having utmost precision, and concerns related to inconsistency of the perfusion improvement data are likely to restrain the growth of the global transmyocardial laser revascularization market during the forecast period. The growth in research and development addressing the issue of consistent myocardial perfusion, along with long term survival without the need of readmission is likely to serve as a major opportunity for the growth of the global transmyocardial laser revascularization market during the forecast period.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39371

The global transmyocardial laser revascularization market can be categorized on the basis of laser modality type, angina stage type, end-user, and region. On the basis of laser modality type, the global transmyocardial laser revascularization market can be bifurcated into holmium:yttrium–aluminum–garnet (Ho:YAG) lasers and Caron Di-oxide (CO2) lasers, which are approved by the FDA. Also, several other experimented wavelength include, but are not limited to xenon–chloride, and neodymium:yttrium–aluminum–garnet (YAG) lasers.

Based on angina stage type, the global transmyocardial laser revascularization market can be classified into angina class I, angina class II, angina class III, and angina class IV. In terms of end-user, the global transmyocardial laser revascularization market can be divided into hospitals, ambulatory surgical centers, & specialty clinics. Among the two FDA approved laser modalities, CO2 laser uses a wavelength of 10,600nm whereas Ho:YAG laser uses 2,120nm wavelength. Studies have shown that CO2 lasers create 3.5 times lesser structural and thermal damage zones to the tissues when compared to Ho:YAG laser, thus resulting in lower volumetric tissue damage.

Request to View ToC of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=39371

Geographically, the global transmyocardial laser revascularization market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is likely to account for a leading share of the global transmyocardial laser revascularization market, during the forecast period, in terms of value, owing to significant adoption rate of transmyocardial laser revascularization technique, favorable reimbursement scenario, and rising prevalence of ischemic heart disease led by lifestyle-related diseases in this region. Asia Pacific is projected to offer significant potential for growth of the transmyocardial laser revascularization market during the forecast period, in terms of value, owing to rising prevalence of diabetes and obesity leading to weakened veins, and increasing per capita expenditure on health care in the region.

Key players operating in the global transmyocardial laser revascularization market having FDA approval are NOVADAQ Technologies Inc., and CryoLife, Inc.

View Report -

https://www.transparencymarketresearch.com/transmyocardial-laser-revascularization-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Transmyocardial Laser Revascularization Market to Develop Rapidly by 2025 here

News-ID: 971914 • Views: 97

More Releases from Transparency Market Research

Fuel Dispenser Market - Global Industry Analysis, Size, Share, Growth, Trends, a …
Albany, NY - Fuel Dispenser Market: Introduction In terms of value, the global fuel dispenser market is expected to reach ~US$ 2 Bn by 2030, expanding at a CAGR of ~4% during the forecast period. Based on volume, the global fuel dispenser market is estimated to reach 662,058 units by 2030, expanding at a CAGR of ~4% during the forecast period. In terms of type, the submersible system segment holds leading
Brazil Flavored and Functional Water Market Outlook, Gains Traction, Analysis An …
According to the report, the market will exhibit an impressive CAGR of 7.3% during the projection period. With this rate of growth, by the end of 2024, the market will be valued around US$9.4 bn. It is a considerable growth from the initial valuation recorded at US$5 bn in 2015. A new report by Transparency Market Research expects the Brazil flavored functional water market to grow at considerable pace over
Advantame Market Trends , Incredible Growth Opportunities, Volume, Value Growth …
Increasing health issues among the population led to an increase in the demand for non-caloric sweetener. In the global food and beverage market, the demand for advantame is on rising owing to its non-caloric sweetener properties. Advantame is one of the most recent, high potency low-calorie sweeteners to arrive in the food and beverage market with clean sugar-like the taste. The rising consumption of unhealthy/ comfort sugary food with high calories
Trends in the Feed ingredients - Outlook, Share and Opportunities in Grooming Re …
Escalating demand for high nutritional value meat is one of the major factor driving the growth of global feed ingredients market. In the global meat products market, safety is one of the major concern among meat manufacturers owing to stringent rules laid by government organizations during the handling, procurement, processing, storage, and distribution of animal products. The inclusion of high nutritive value feed ingredient into animal feed results in more

All 5 Releases


More Releases for Transmyocardial

Indian Cardiology Market Research and Forecast, 2018-2023
The report published by Orion Market Research (OMR) is on the Indian cardiology surgery market which is expected to grow significantly during the forecast period 2018-2023. Cardiovascular devices in the Indian market are beneficial in technological advancements and low-cost medication which are dominated by domestic manufacturers. These manufacturers are playing a vital role in the Indian market to grow it substantially as a medical giant to attract investors. Innovation
Indian Cardiology Market: Industry Analysis and Opportunity Assessment, 2019 – …
Indian Cardiology Industry New Study On “2019-2023 Cardiology Market Indian Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database The Indian cardiology market is expected to grow at a significant growth rate during the forecast period. The report covers the Indian cardiology market in surgeries, drugs, and devices. The market is growing rapidly due to improving quality and operation standards in the country, variation in the lifestyle
Cardiovascular Devices Markets to 2022: Abbott Vascular, Abiomed Inc., B. Braun …
Researchmoz added Most up-to-date research on "Cardiovascular Devices: Global Markets to 2022" to its huge collection of research reports. The global market for cardiovascular devices reached nearly $42.4 billion in 2017 and should reach $59.1 billion by 2022, at a compound annual growth rate (CAGR) of 6.9% for the period of 2017-2022. Report Includes An overview of the global markets for cardiovascular devices Analyses of global market trends, with data from 2016, estimates for
Global Cardiology Surgery, Devices and Drugs Market 2018 Share, Trend, Segmentat …
Global Cardiology Surgery, Devices and Drugs Industry New Study On “2018-2023 Cardiology Surgery, Devices and Drugs Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database The global cardiology devices & drugs market is expected to grow at a CAGR of 7.4% for the forecasted period of 2018-2023. The report covers three major segments of interventional cardiology market which include surgeries, devices, and drugs. As per
Transmyocardial Laser Revascularization Market - Latest Trends and Future Growth …
Transmyocardial laser revascularization has emerged as a better treatment alternative for ischemic heart disease patients who are unable to undergo surgeries such as coronary artery bypass graft surgery or stenting by balloon angioplasty. Introduced in 1990, transmyocardial laser revascularization (TMLR) procedure bores small holes from the ventricle into the myocardium and provides significant relief to angina patients by allowing the direct flow of blood to heart muscles, thereby surpassing the
Cardiology Surgical & Interventional Cardiology Devices Market by Country (Unite …
The prevalence of heart diseases globally increases the demand for interventional cardiology surgeries. The cardiology surgeries are costly and have some risk factor attached - there is 3-5% probability of patient’s death. The global increase in life style oriented diseases has indirectly put pressure on the economies of the nation. The patient alone does not bear the cost of the treatment. The funding comes from the government health programs, reimbursement